Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.190
+0.070 (1.70%)
At close: May 29, 2026, 4:00 PM EDT
4.323
+0.133 (3.17%)
After-hours: May 29, 2026, 5:43 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $541.11 million as of May 29, 2026. Its market cap has increased by 56.49% in one year.
Market Cap
541.11M
Enterprise Value
306.36M
1-Year Change
56.49%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $541.11M, a decrease of -76.07%. That is a compound annual growth rate of -25.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 541.11M | -16.20% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 639.07M |
| BrainsWay | 633.64M |
| NeuroPace | 592.89M |
| Cerus | 585.08M |
| Tactile Systems Technology | 576.31M |
| Beta Bionics | 539.20M |
| Perspective Therapeutics | 461.89M |
| OrthoPediatrics | 457.45M |